Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.0K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

2.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

689
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
689
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

1.4K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.4K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

640
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
640
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.1K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CIITA/PRMT5 promote CD4<sup>+</sup>Gzma<sup>+</sup> T cell activation via H3R2me2-mediated endothelial expression of MHC class II in smoking-induced atherosclerosis.

BMC medicine·2026
Same author

Extracellular vesicles derived by hypoxic preconditioned EPCs attenuated atherosclerosis by suppressing ferroptosis via regulating arginine metabolism.

Redox biology·2026
Same author

Culprit lesion characteristics and prognosis in STEMI with cold onset: an OCT study.

NPJ cardiovascular health·2026
Same author

Author Correction: Culprit lesion characteristics and prognosis in STEMI with cold onset: an OCT study.

NPJ cardiovascular health·2026
Same author

Retinoic acid rescues heat stress-induced estrous cycle disruption by enhancing Cyp19a1 expression through the Ca2+-pSTAT3-H3K27me3 axis†.

Biology of reproduction·2026
Same author

Predicting polyvascular disease with optical coherence tomography angiography and/or optical coherence tomography.

BMC cardiovascular disorders·2026
Same journal

Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of COVID-19: A Meta-Analysis.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Timing Matters: Effects of Early and Late Estrogen Replacement Therapy on Glucose Metabolism and Vascular Reactivity in Ovariectomized Aged Wistar Rats.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Genetic Variants Associated with High Susceptibility of Premature Ischemic Stroke.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
See all related articles

Related Experiment Video

Updated: Nov 28, 2025

A Fluorescence-Based Assay of Membrane Potential for High-Throughput Functional Study of Two Endogenous Ion Channels in Two Epithelial Cell Lines
06:59

A Fluorescence-Based Assay of Membrane Potential for High-Throughput Functional Study of Two Endogenous Ion Channels in Two Epithelial Cell Lines

Published on: June 22, 2022

2.4K

Amiloride: A review.

Qianhui Sun1, Peter Sever2

  • 1Imperial College London, Faculty of Medicine, Faculty Building, Level 2, London, UK.

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|November 25, 2020
PubMed
Summary
This summary is machine-generated.

Amiloride, a diuretic, effectively treats hypertension by blocking sodium channels. Further research is needed to determine optimal dosing for mild to moderate hypertension, building on its proven benefits in specific patient groups.

Keywords:
Amiloridediuretichypertensionnatriureticreview

More Related Videos

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

639
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.8K

Related Experiment Videos

Last Updated: Nov 28, 2025

A Fluorescence-Based Assay of Membrane Potential for High-Throughput Functional Study of Two Endogenous Ion Channels in Two Epithelial Cell Lines
06:59

A Fluorescence-Based Assay of Membrane Potential for High-Throughput Functional Study of Two Endogenous Ion Channels in Two Epithelial Cell Lines

Published on: June 22, 2022

2.4K
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

639
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.8K

Area of Science:

  • Pharmacology
  • Nephrology
  • Cardiology

Background:

  • Amiloride is a potassium-sparing diuretic and natriuretic agent.
  • It functions by reversibly blocking epithelial sodium channels (ENaCs) in the renal tubules.
  • Established indications include edema, potassium conservation, and adjunct therapy for hypertension, heart failure, and cirrhosis.

Purpose of the Study:

  • To review the evidence for amiloride's efficacy in hypertension.
  • To identify gaps in knowledge regarding its dose-response relationship, particularly in mild to moderate hypertension.
  • To assess its potential role in a broader hypertensive patient population.

Main Methods:

  • Review of historical and recent clinical studies on amiloride.
  • Analysis of its use in specific trials, including the Medical Research Council Trial of Older Hypertensive Patients.
  • Comparison with other antihypertensive agents like spironolactone.

Main Results:

  • Amiloride is effective in combination with thiazide diuretics, counteracting metabolic side effects.
  • Demonstrated benefits in reducing stroke and coronary events in older hypertensive patients.
  • Recent studies show comparable efficacy to spironolactone in resistant hypertension.

Conclusions:

  • Amiloride has proven benefits in specific hypertensive populations and in combination therapy.
  • There is a significant need for more data on amiloride's efficacy and dose-response in mild to moderate hypertension.
  • Further investigation is warranted to establish its role in managing a larger segment of hypertensive patients.